 |
|
|
May. 16, 2013
Kamada announces extension to strategic agreement with Baxter |
May. 6, 2013
|
Upcoming Event
Kamada to participate at the American Thoracic Society International Conference |
High Quality Pharmaceuticals
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology. |
Alpha-1Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic condition which can cause serious liver disease in children and liver and/or lung disease in adults. The most common clinical presentation of Alpha-1 Deficiency is lung disease. That is the reason it is also called "Inherited Emphysema" or "Genetic COPD". |
Kamada Highlights Video
|
